Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03984331 · ClinicalTrials.gov registry record · NA
Fish Skin Compared to Cadaver Skin as Temporary Cover for Full Thickness Burns
A NA study, sponsored by Kerecis.
- Completed
- Registry status
- NA
- Development phase
- 5
- Enrollment target
NCT03984331: Completed NA study, sponsored by Kerecis.
NCT03984331 is a NA study that has completed, run by Kerecis. The registered enrollment target is 5 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03984331, a NA study, has completed, sponsored by Kerecis.
- COMPLETED
- Registry status
- NA
- Development phase
- 5 participants
- Enrollment target
Study Summary
Objectives and rationale: Optimal burn management involves removing all the dead or burned tissue as early as feasible and cover with an autograft called split thickness skin graft (STSG) taken from the patient. This procedure creates a new wound on the patient and sometimes, when the burn covers very large portion of the patient body, there is a lack of healthy skin to use for this purpose. Under those circumstances, donated cadaver skin is used as a temporary coverage until the patient´s own donor site wound has healed enough to be used again. The proposed clinical study aims to determine if treatment with fish skin is an alternative to cadaver skin as a temporary coverage for debrided full-thickness burns prior to STSG in terms of autograft take, time to heal, quality of healing (scarring), pain and adverse effects.
Primary Outcome
Wounds which have reached at least 95% epithelialization
Interventions
- DEVICE Fish skin
- DEVICE Cadaver skin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2019-02-14 |
| Est. Completion | 2021-09-21 |
| Phase | NA |
What the finished NCT03984331 record still lists
NCT03984331 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 5 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 2 interventions - of which Fish skin is the first listed.
NCT03984331 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03984331 about?
NCT03984331 is a clinical study titled "Fish Skin Compared to Cadaver Skin as Temporary Cover for Full Thickness Burns". Objectives and rationale: Optimal burn management involves removing all the dead or burned tissue as early as feasible and cover with an autograft called split thickness skin graft (STSG) taken from the patient. This procedure creates a new wound on the patient and sometimes, when the burn covers ve...
What is the current status of trial NCT03984331?
This trial is currently completed. It is a NA study. The enrollment target is 5 participants. The study started on 2019-02-14. Estimated completion is 2021-09-21.
What interventions are being tested in trial NCT03984331?
The interventions under investigation include: Fish skin (DEVICE), Cadaver skin (DEVICE).
Who is sponsoring clinical trial NCT03984331?
This trial is sponsored by Kerecis, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03984331's enrollment target sits among peer trials
5 1988th of 2000 higher than 5 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI